NCT03744962Unknown不适用
A Compare of Microsatellite Instability in Circulatory DNA and Tumor Tissue of Endometrial Cancer
Lei Li1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年11月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Frequency of microsatellite instability
研究概览
简要总结
This study aims to analyze the microsatellite instability (MSI) in the circulatory tumor DNA and in the tumor tissue in the patients diagnosed with uterine endometrial cancer. These data will be used for the study of "Cohort Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer" (NCT03291106, clinicaltrials.gov).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Confirmed primary endometrial cancer before any surgical or chemotherapy treatment
- •Signed an approved informed consents
- •Feasible for sampling
排除标准
- •Not meeting all of the inclusion criteria
结局指标
主要结局
Frequency of microsatellite instability
时间窗: Two years
Frequencies of different status of microsatellite instability (high microsatellite instability or microsatellite-stable) in the circulatory tumor DNA and in the tumor tissue
次要结局
未报告次要终点
研究者
Lei Li
Professor
Peking Union Medical College Hospital
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid TumorsSolid TumorNCT03596593Peking University8,000
招募中
不适用
ctDNA-based MRD Assessment in Local Advanced Esophageal CarcinomaEsophageal Squamous Cell CarcinomaNCT05426850Fudan University100
已完成
不适用
Molecular Characteristics of Early-onset Compared With Late-onset Colorectal CancerMicrosatellite InstabilityColorectal CancerNCT06238193The First Affiliated Hospital with Nanjing Medical University11,344
进行中（未招募）
Unknown
Whether high-risk features (HRFs) on the recurrence or microsatellite instability (MSI) status are predictive markers for adjuvant chemotherapy (ACT) in patients with stage II colon cancer is uncertain. This study aimed to examine the impact of HRFs and MSI on the prediction of the benefits of ACT in patients with stage II colon cancer. This multi-center retrospective study included 1801 patients with resected stage II colon cancer diagnosed at 17 university-affiliated hospitals between January 2010 and December 2017.NeoplasmsKCT0009579Keimyung University Dongsan Hospital1,300
Unknown
不适用
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation SequencingColorectal NeoplasmsNCT03561350Shanghai Minimally Invasive Surgery Center60